Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

5-alpha reductase inhibitors do not increase hip fracture risk.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Finasteride safely lowers DHT levels without affecting testosterone.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Dutasteride may protect the brain in early Parkinson's disease.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The method effectively measures drug impact on DHT levels in prostate treatments.

Dutasteride and finasteride can change semen and hormone levels in men.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

A new combination of tadalafil and finasteride improves drug performance and stability.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Combining tadalafil and finasteride improves their solubility and effectiveness.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.